Evidence map›Paper›PMID 41080926›Full record

ArticleJournal of diabetes and metabolic disorders2025

Amino acid metabolic signatures of dynapenic obesity in older adults: a (principal component analysis) PCA-based sex-stratified analysis in the Bushehr elderly health program.

Maryam Kheirandish, Neda Cheraghloo, Nafiseh Tavasoli, Farideh Razi, Farima Farsi, Atefeh Amrollahi Bioky, Hamid Reza Aghaei Meybodi, Kazem Khalagi, Ramin Heshmat, Niloufar Najjar and 4 more

Abstract read
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Maryam Kheirandish *Department of Endocrinology, School of Medicine, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Neda Cheraghloo *Department of Epidemiology and Biostatistics, School of public health, Tehran University of Medical Sciences, Tehran, Iran.
Nafiseh TavasoliEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Farideh RaziMetabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Farima FarsiEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Atefeh Amrollahi BiokyEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Hamid Reza Aghaei MeybodiEvidence-Based Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Kazem KhalagiOsteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Ramin HeshmatChronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Niloufar NajjarMetabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Maryam Amini ShirkouhiMetabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Iraj NabipourThe Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran.
Gita ShafieeChronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Bagher LarijaniEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Dynapenic obesity (DO), the co-occurrence of muscle strength loss and obesity in aging adults, exacerbates metabolic dysfunction and disability risks. While amino acid (AA) dysregulation is implicated in both conditions, their combined metabolic signature remains unexplored. We aimed to identify sex-specific amino acid metabolic patterns associated with DO in Iranian older people. Methods: In this cross-sectional study of 1,928 adults (aged 50 years or older) from the Bushehr Elderly Health Program, serum AA profiles were quantified using UPLC-MS/MS. Principal component analysis (PCA) derived four factors from 20 AAs.Dynapenia thresholds were handgrip strength < 26 kg (men) and < 18 kg (women). Abdominal obesity was defined as a waist circumference ≥ 102 cm (men) or ≥ 88 cm (women). Multinomial logistic regression was used to evaluate the associations between these factors and dynapenia/obesity phenotypes, stratified by sex and adjusted for confounders. Results: The study included 1928 people (57.2% women; mean age 61.6 ± 7.7 years) after excluding subjects with missing values. Four distinct amino acid factors reflecting major metabolic pathways: insulin resistance with branched-chain and aromatic amino acids (Factor 1), nitrogen and methyl group metabolism (Factor 2), anabolic capacity and protein turnover (Factor 3), and urea cycle function and detoxification (Factor 4). In women, Factor 1(Leucine, Valine, Tyrosine, Alanine, Methionine, Tryptophan, and Proline) was positively linked to nondynapenic obesity [RR = 1.55 (1.15-2.08)] and DO [RR = 1.35(0.99-1.84, Conclusions: This study found distinct amino acid signatures associated with dynapenia and obesity in older adults. Factor 1 highlighted the role of insulin resistance-related amino acids in obesity across both genders, while Factor 2 emphasized nitrogen metabolism and its association with muscle loss and adiposity primarily in men. Factor 3's anabolic profile suggested a complex but modest link to obesity and muscle health, and factor 4 underscored the protective effects of efficient nitrogen detoxification against obesity in women. These results reveal sex-specific metabolic pathways involved in dynapenic obesity, offering potential targets for personalized treatments to improve muscle and metabolic health in aging populations. Further research is needed to confirm these findings and explore therapeutic applications. Supplementary information: The online version contains supplementary material available at 10.1007/s40200-025-01746-x.

Indexed as

Amino acidsDynapeniaElderlyMetabolomicsObesity

Identifiers

PMID41080926
PMCPMC12514097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.